Indication

For the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.

Medicine details

Medicine name:
ponesimod (Ponvory)
SMC ID:
SMC2384
Pharmaceutical company
Janssen-Cilag Ltd
BNF chapter
Central nervous system
Submission type
Abbreviated
Publication due date:
08 November 2021